{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:13:18Z","timestamp":1790500398634,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministry of Education Youth and Sports of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["20-19638Y"],"award-info":[{"award-number":["20-19638Y"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bioorg.2021.104806","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T18:35:35Z","timestamp":1615055735000},"page":"104806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review"],"prefix":"10.1016","volume":"110","author":[{"given":"Ghada","family":"Bouz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.104806_b0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/156802612799984571","article-title":"Adenylating enzymes in Mycobacterium tuberculosis as drug targets","volume":"12","author":"Duckworth","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0300-483X(00)00454-6","article-title":"Genomics-based identification of targets in pathogenic bacteria for potential therapeutic and diagnostic use","volume":"160","author":"Raczniak","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.bioorg.2021.104806_b0015","article-title":"Aminoacyl-tRNA Synthetases., Madame Curie Bioscience Database [Internet]","author":"Sissler","year":"2000","journal-title":"Landes Bioscience, Austin (TX)"},{"key":"10.1016\/j.bioorg.2021.104806_b0020","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1039\/C9MD00139E","article-title":"Recent development of leucyl-tRNA synthetase inhibitors as antimicrobial agents","volume":"10","author":"Zhang","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bioorg.2021.104806_b0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.18388\/abp.2000_4000","article-title":"The new aspects of aminoacyl-tRNA synthetases","volume":"47","author":"Szymanski","year":"2000","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bioorg.2021.104806_b0030","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1128\/JB.01726-08","article-title":"The Molecular Alarmone (p)ppGpp Mediates Stress Responses, Vancomycin Tolerance, and Virulence in Enterococcus faecalis","volume":"191","author":"Abranches","year":"2009","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bioorg.2021.104806_b0035","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1073\/pnas.88.18.8121","article-title":"EVOLUTION AND RELATEDNESS IN 2 AMINOACYL-TRANSFER RNA-SYNTHETASE FAMILIES","volume":"88","author":"Nagel","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bioorg.2021.104806_b0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/347203a0","article-title":"Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs","volume":"347","author":"Eriani","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.104806_b0045","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1128\/AAC.49.12.4821-4833.2005","article-title":"Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents","volume":"49","author":"Hurdle","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.bioorg.2021.104806_b0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/BF02705188","article-title":"Chemistry of aminoacylation and peptide bond formation on the 3 ' terminus of tRNA","volume":"31","author":"Sprinzl","year":"2006","journal-title":"Journal of Biosciences"},{"key":"10.1016\/j.bioorg.2021.104806_b0055","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1021\/bi00875a037","article-title":"SOME OBSERVATIONS RELATING TO ACYL MOBILITY IN AMINOACYL SOLUBLE RIBONUCLEIC ACIDS","volume":"5","author":"Griffin","year":"1966","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2021.104806_b0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/5584_2017_93","article-title":"Coding of Class I and II Aminoacyl-tRNA Synthetases","volume":"966","author":"Carter","year":"2017","journal-title":"Advances in experimental medicine and biology"},{"key":"10.1016\/j.bioorg.2021.104806_b0065","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1016\/j.febslet.2013.08.037","article-title":"Aminoacylation of tRNA 2 '- or 3 '-hydroxyl by phosphoseryl- and pyrrolysyl-tRNA synthetases","volume":"587","author":"Englert","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2021.104806_b0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev.micro.091208.073210","article-title":"Aminoacyl-tRNA Synthesis and Translational Quality Control","volume":"63","author":"Ling","year":"2009","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bioorg.2021.104806_b0075","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1042\/bj1281353","article-title":"The frequency of errors in protein biosynthesis","volume":"128","author":"Loftfield","year":"1972","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2021.104806_b0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/15476286.2017.1397262","article-title":"A continuous assay for monitoring the synthetic and proofreading activities of multiple aminoacyl-tRNA synthetases for high-throughput drug discovery","volume":"15","author":"Grube","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.bioorg.2021.104806_b0085","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1074\/jbc.REV118.002956","article-title":"Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics","volume":"294","author":"Francklyn","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1107\/S2053230X18003151","article-title":"The crystal structure of the drug target Mycobacterium tuberculosis methionyl-tRNA synthetase in complex with a catalytic intermediate","volume":"74","author":"Barros-Alvarez","year":"2018","journal-title":"Acta Crystallographica Section F-Structural Biology Communications"},{"key":"10.1016\/j.bioorg.2021.104806_b0095","first-page":"1","article-title":"Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites","volume":"4","author":"Pham","year":"2014","journal-title":"International Journal for Parasitology: Drugs and Drug Resistance"},{"key":"10.1016\/j.bioorg.2021.104806_b0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1021\/acsinfecdis.6b00078","article-title":"Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target","volume":"3","author":"Hewitt","year":"2017","journal-title":"Prolyl-tRNA-synthetase, ACS Infectious Diseases"},{"key":"10.1016\/j.bioorg.2021.104806_b0105","doi-asserted-by":"crossref","first-page":"47387","DOI":"10.1074\/jbc.M109089200","article-title":"Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase","volume":"276","author":"Nakama","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0190-9622(90)70116-Y","article-title":"THE CLINICAL DEVELOPMENT OF MUPIROCIN","volume":"22","author":"Pappa","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioorg.2021.104806_b0115","first-page":"229","article-title":"Impetigo: Diagnosis and Treatment","volume":"90","author":"Hartman-Adams","year":"2014","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.bioorg.2021.104806_b0120","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0195-6701(01)90005-2","article-title":"MRSA patients: proven methods to treat colonization and infection","volume":"48","author":"Boyce","year":"2001","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.bioorg.2021.104806_b0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s15010-005-4012-9","article-title":"Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections","volume":"33","author":"Kluytmans","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.bioorg.2021.104806_b0130","first-page":"6185","article-title":"Spotlight on tavaborole for the treatment of onychomycosis","volume":"9","author":"Jinna","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioorg.2021.104806_b0135","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/14656566.2019.1571039","article-title":"Pharmacotherapy for onychomycosis: new and emerging treatments","volume":"20","author":"Lipner","year":"2019","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bioorg.2021.104806_b0140","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/161400b0","article-title":"Pharmacology of Ch\u2018ang Shan (Dichroa febrifuga), a Chinese Antimalarial Herb","volume":"161","author":"Jang","year":"1948","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.104806_b0145","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.bmc.2018.04.027","article-title":"Chemical synthesis of febrifugine and analogues","volume":"26","author":"Smullen","year":"2018","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0150","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157340609788185846","article-title":"Synthesis and Comparison of Antimalarial Activity of Febrifugine Derivatives Including Halofuginone","volume":"5","author":"Samant","year":"2009","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0155","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1083-8791(03)00151-4","article-title":"Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma","volume":"9","author":"Pines","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.bioorg.2021.104806_b0160","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0960-894X(99)00206-1","article-title":"Methionyl adenylate analogues as inhibitors of methionyl-tRNA synthetase","volume":"9","author":"Lee","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104806_b0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bmc.2006.09.056","article-title":"Synthesis of beta-ketophosphonate analogs of glutamyl and glutaminyl adenylate, and selective inhibition of the corresponding bacterial aminoacyl-tRNA synthetases","volume":"15","author":"Balg","year":"2007","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0170","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0960-894X(01)00095-6","article-title":"Ester and hydroxamate analogues of methionyl and isoleucyl adenylates as inhibitors of methionyl-tRNA and isoleucyl-tRNA synthetases","volume":"11","author":"Lee","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104806_b0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2019.04.045","article-title":"Acylated sulfonamide adenosines as potent inhibitors of the adenylate-forming enzyme superfamily","volume":"174","author":"De Ruysscher","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0167-4838(91)90138-P","article-title":"X-RAY CRYSTALLOGRAPHIC CONFORMATIONAL STUDY OF 5'-O- N-(L-ALANYL)-SULFAMOYL ADENOSINE, A SUBSTRATE-ANALOG FOR ALANYL TRANSFER-RNA SYNTHETASE","volume":"1080","author":"Ueda","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2021.104806_b0185","article-title":"Cubist Pharmaceuticals Inc, USA. Preparation of aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents","author":"Hill","year":"1997","journal-title":"WO9705132A1."},{"key":"10.1016\/j.bioorg.2021.104806_b0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/bioo.1996.0025","article-title":"Synthesis and aminoacyl-tRNA synthetase inhibitory activity of prolyl adenylate analogs","volume":"24","author":"Heacock","year":"1996","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0195","doi-asserted-by":"crossref","unstructured":"H. Belrhali, A. Yaremchuk, M. Tukalo, K. Larsen, C. Berthetcolominas, R. Leberman, B. Beijer, B. Sproat, J. Alsnielsen, G. Grubel, J.F. Legrand, M. Lehmann, S. Cusack, CRYSTAL-STRUCTURES AT 2.5 ANGSTROM RESOLUTION OF SERYL-TRANSFER-RNA SYNTHETASE COMPLEXED 2 ANALOGS OF SERYL ADENYLATE, Science, 263 (1994) 1432-1436. https:\/\/doi.org\/10.1126\/science.8128224.","DOI":"10.1126\/science.8128224"},{"key":"10.1016\/j.bioorg.2021.104806_b0200","doi-asserted-by":"crossref","unstructured":"J.S. Cisar, J.A. Ferreras, R.K. Soni, L.E.N. Quadri, D.S. Tan, Exploiting ligand conformation in selective inhibition of non-ribosomal peptide synthetase amino acid adenylation with designed macrocyclic small molecules, Journal of the American Chemical Society, 129 (2007) 7752-+. https:\/\/doi.org\/10.1021\/ja0721521.","DOI":"10.1021\/ja0721521"},{"key":"10.1016\/j.bioorg.2021.104806_b0205","unstructured":"WHO, Global tuberculosis report 2020. Geneva: World Health Organization; 2020., DOI (2020)."},{"key":"10.1016\/j.bioorg.2021.104806_b0210","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jmb.2008.01.016","article-title":"On the evolution of the tRNA-dependent amidotransferases, GatCAB and GatDE","volume":"377","author":"Sheppard","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2021.104806_b0215","doi-asserted-by":"crossref","first-page":"11819","DOI":"10.1073\/pnas.94.22.11819","article-title":"Glu-tRNAGln amidotransferase: A novel heterotrimeric enzyme required for correct decoding of glutamine codons during translation","volume":"94","author":"Curnow","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.bioorg.2021.104806_b0220","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1128\/AAC.01339-16","article-title":"Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase","volume":"60","author":"Palencia","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.bioorg.2021.104806_b0225","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1021\/acs.jmedchem.7b00631","article-title":"Discovery of a Potent and Specific M-tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2hydroxyethoxy)benzo c 1,2 oxaborol-1(3 H)-ol (GSK656)","volume":"60","author":"Li","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0230","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00240-19","article-title":"First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment","volume":"63","author":"Tenero","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.bioorg.2021.104806_b0235","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14756366.2016.1190712","article-title":"Identification of Mycobacterium tuberculosis leucyl-tRNA synthetase (LeuRS) inhibitors among the derivatives of 5-phenylamino-2H- 1,2,4 triazin-3-one","volume":"31","author":"Gudzera","year":"2016","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2021.104806_b0240","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bmc.2016.01.028","article-title":"Discovery of potent anti-tuberculosis agents targeting leucyl-tRNA synthetase","volume":"24","author":"Gudzera","year":"2016","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0245","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1021\/bi000108r","article-title":"CP1 domain in Escherichia coli leucyl-tRNA synthetase is crucial for its editing function","volume":"39","author":"Chen","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2021.104806_b0250","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1039\/C9MD00347A","article-title":"Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N '-thiazol-2-yl-hydrazines","volume":"10","author":"Kovalenko","year":"2019","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2021.104806_b0255","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061307","article-title":"Synthesis, Characterization, and Biological Evaluation of Novel 7-Oxo-7H-thiazolo 3,2-b -1,2,4-triazine-2-carboxylic Acid Derivatives","volume":"25","author":"Cai","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2021.104806_b0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1371\/journal.pone.0147188","article-title":"Essentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatis","volume":"11","author":"Ravishankar","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2021.104806_b0265","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1021\/bi012212u","article-title":"ATP-dependent L-cysteine:1D-myo-inosityl 2-amino-2-deoxy-alpha-D-glucopyranoside ligase, mycothiol biosynthesis enzyme MshC, is related to class I cysteinyl-tRNA synthetases","volume":"41","author":"Sareen","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2021.104806_b0270","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1016\/j.bmcl.2011.02.042","article-title":"Susceptibility and mode of binding of the Mycobacterium tuberculosis cysteinyl transferase mycothiol ligase to tRNA synthetase inhibitors","volume":"21","author":"Gutierrez-Lugo","year":"2011","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.bioorg.2021.104806_b0275","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1046\/j.1365-2958.2003.03416.x","article-title":"Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics","volume":"47","author":"Buchmeier","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2021.104806_b0280","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1107\/S2052252518008217","article-title":"Structural characterization of free-state and product-state Mycobacterium tuberculosis methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism","volume":"5","author":"Wang","year":"2018","journal-title":"IUCrJ"},{"key":"10.1016\/j.bioorg.2021.104806_b0285","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00253-003-1243-5","article-title":"Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics","volume":"61","author":"Kim","year":"2003","journal-title":"Applied Microbiology and Biotechnology"},{"key":"10.1016\/j.bioorg.2021.104806_b0290","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/jac\/dkv110","article-title":"Identification of an anti-TB compound targeting the tyrosyl-tRNA synthetase","volume":"70","author":"Zhu","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2021.104806_b0295","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00249-014-0991-8","article-title":"Structural states of the flexible catalytic loop of M-tuberculosis tyrosyl-tRNA synthetase in different enzyme-substrate complexes","volume":"43","author":"Mykuliak","year":"2014","journal-title":"European Biophysics Journal with Biophysics Letters"},{"key":"10.1016\/j.bioorg.2021.104806_b9000","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35701-z","article-title":"IMB-T130 targets 3-dehydroquinate synthase and inhibits Mycobacterium tuberculosis","volume":"8","author":"Zhu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2021.104806_b0300","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bmcl.2013.12.022","article-title":"Synthesis and biological evaluation of 2-aminothiazole derivatives as antimycobacterial and antiplasmodial agents","volume":"24","author":"Mjambili","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104806_b0305","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1016\/j.bmc.2013.08.048","article-title":"Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis","volume":"21","author":"Meissner","year":"2013","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0310","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1039\/C8MD00056E","article-title":"Design, synthesis and antimycobacterial activity of hybrid molecules combining pyrazinamide with 4-phenylthiazol-2-amine scaffold","volume":"9","author":"Zitko","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2021.104806_b0315","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejmech.2013.11.020","article-title":"Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity","volume":"75","author":"Li","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0320","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/jm501402x","article-title":"Promiscuous 2-Aminothiazoles (PrATs): A Frequent Hitting Scaffold","volume":"58","author":"Devine","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0325","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/qua.24814","article-title":"In Silico based Virtual Screening and Mixed Mode QM\/MM Calculation Identifies Caffeine Scaffold for Designing Potential Inhibitors for Tyrosyl tRNA Synthetase of Mycobacterium tuberculosis","volume":"115","author":"Sathya","year":"2015","journal-title":"International Journal of Quantum Chemistry"},{"key":"10.1016\/j.bioorg.2021.104806_b0330","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1039\/c2md20032e","article-title":"Aminoacyl tRNA synthetases as targets for antibiotic development","volume":"3","author":"Agarwal","year":"2012","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2021.104806_b0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075245","article-title":"Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis","volume":"8","author":"Ioerger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bioorg.2021.104806_b0340","doi-asserted-by":"crossref","first-page":"12664","DOI":"10.1038\/s41598-018-31157-3","article-title":"Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach","volume":"8","author":"Soto","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2021.104806_b0345","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1371\/journal.ppat.1000534","article-title":"The Two-Domain LysX Protein of Mycobacterium tuberculosis Is Required for Production of Lysinylated Phosphatidylglycerol and Resistance to Cationic Antimicrobial Peptides","volume":"5","author":"Maloney","year":"2009","journal-title":"Plos Pathogens"},{"key":"10.1016\/j.bioorg.2021.104806_b0350","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/21505594.2020.1713690","article-title":"Mutation on lysX from Mycobacterium avium hominissuis impacts the host-pathogen interaction and virulence phenotype","volume":"11","author":"Kirubakar","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.bioorg.2021.104806_b0355","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2180-12-204","article-title":"Illegitimate recombination: An efficient method for random mutagenesis in Mycobacterium avium subsp hominissuis","volume":"12","author":"Khattak","year":"2012","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.bioorg.2021.104806_b0360","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1021\/acs.jmedchem.8b00565","article-title":"Specific Stereoisomeric Conformations Determine the Drug Potency of Cladosporin Scaffold against Malarial Parasite","volume":"61","author":"Das","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104806_b0365","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/prot.25699","article-title":"Side chain rotameric changes and backbone dynamics enable specific cladosporin binding in Plasmodium falciparum lysyl-tRNA synthetase, Proteins: Struct","volume":"87","author":"Chhibber-Goel","year":"2019","journal-title":"Funct. Bioinform."},{"key":"10.1016\/j.bioorg.2021.104806_b0370","doi-asserted-by":"crossref","DOI":"10.1080\/23312009.2016.1181536","article-title":"Small-molecule inhibitors of the tuberculosis target, phenylalanyl-tRNA synthetase from Penicillium griseofulvum CPCC-400528","volume":"2","author":"Wang","year":"2016","journal-title":"Cogent Chemistry"},{"key":"10.1016\/j.bioorg.2021.104806_b0375","first-page":"288","article-title":"ANTITUMOR-ACTIVITY OF PATULIN AND STRUCTURAL ANALOGS","volume":"47","author":"Seiglemurandi","year":"1992","journal-title":"Pharmazie"},{"key":"10.1016\/j.bioorg.2021.104806_b0380","first-page":"573","article-title":"MR-proANP level predicts new onset atrial fibrillation in patients with acute myocardial infarction","volume":"25","author":"Karolina","year":"2020","journal-title":"Research Square"},{"key":"10.1016\/j.bioorg.2021.104806_b0385","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1021\/bi9603027","article-title":"A eubacterial Mycobacterium tuberculosis tRNA synthetase is eukaryote-like and resistant to a eubacterial-specific antisynthetase drug","volume":"35","author":"Sassanfar","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2021.104806_b0390","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1742-4658.2009.06880.x","article-title":"Kinetic and mechanistic characterization of Mycobacterium tuberculosis glutamyl-tRNA synthetase and determination of its oligomeric structure in solution","volume":"276","author":"Paravisi","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2021.104806_b0395","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.abb.2008.02.015","article-title":"The biochemistry of heme biosynthesis","volume":"474","author":"Heinemann","year":"2008","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/j.bioorg.2021.104806_b0400","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/14756360400002007","article-title":"Glutamylsulfamoyladenosine and pyroglutamylsulfamoyladenosine are competitive inhibitors of E-coli glutamyl-tRNA synthetase","volume":"20","author":"Bernier","year":"2005","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"10.1016\/j.bioorg.2021.104806_b0405","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1177\/1087057115591120","article-title":"Identification of Chemical Compounds That Inhibit the Function of Glutamyl-tRNA Synthetase from Pseudomonas aeruginosa","volume":"20","author":"Hu","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.bioorg.2021.104806_b0410","unstructured":"J.K. Sello, J.J. Vecchione. Brown University, USA . Combination of an aminoacyl-tRNA synthetase inhibitor with a further antibacterial agent for attenuating multiple drug resistance. WO2012054738A1. 2012."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821001838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821001838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:19:49Z","timestamp":1758615589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821001838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":83,"alternative-id":["S0045206821001838"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104806","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104806"}}